CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL

The goal of this clinical trial is to investigate whether a short-term (4-week) whole-food, plant-based (WFPB) diet has an effect on metabolism, immune function, and disease activity in early-stage chronic lymphocytic leukemia (CLL). The main questions the study aims to answer are: * Does a WFPB diet influence disease progression? * How do CLL cells and other immune cell types respond to a WFPB diet in terms of metabolism and signaling? Researchers will examine whether a WFPB diet can affect absolute lymphocyte counts in participants' blood and what metabolic or functional changes occur with

Trial Details

NCT ID
NCT07487428
Phase
NA
Sponsor
Technical University of Munich
Status
RECRUITING
Cancer Type
Leukemia
Interventions
  • Diet
Locations (sample)
  • München, Bavaria, Germany|48.69668,13.46314

Key Eligibility Criteria

  • Confirmed CLL diagnosis
  • No previous treatments (watch and wait)
  • Willingness to comply to a whole-food plant-based diet for 4 weeks
  • Willingness to participate in a total of 3 blood drawings

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Leukemia Trials on Trialify →